Targeting HDAC6 improves anti-CD47 immunotherapy.
Gracia-Hernandez M, Yende AS, Gajendran N, Alahmadi Z, Li X, Munoz Z, Tan K, Noonepalle S, Shibata M, Villagra A.
Gracia-Hernandez M, et al. Among authors: li x.
J Exp Clin Cancer Res. 2024 Feb 27;43(1):60. doi: 10.1186/s13046-024-02982-4.
J Exp Clin Cancer Res. 2024.
PMID: 38414061
Free PMC article.